tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Venture Life CEO Sells Shares to Fund Option Exercise and Tax Liabilities

Story Highlights
  • Venture Life’s CEO sold 387,705 shares to fund option exercise costs and related taxes.
  • After the sale, Jerry Randall still holds 2,348,828 shares, about 1.82% of Venture Life’s equity.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Venture Life CEO Sells Shares to Fund Option Exercise and Tax Liabilities

Claim 70% Off TipRanks Premium

Venture Life ( (GB:VLG) ) has provided an update.

Venture Life Group has disclosed that chief executive Jerry Randall has sold 387,705 ordinary shares at a volume-weighted average price of 66.22 pence per share to cover the exercise price and personal tax liabilities arising from the recent exercise of options over 483,333 shares. Following the disposal, Randall retains a beneficial holding of 2,348,828 ordinary shares, representing about 1.82% of the company’s issued share capital, providing investors with updated visibility on executive ownership levels and aligning the transaction with market abuse regulation disclosure requirements.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company focused on commercialising over-the-counter health products for the global self-care market. Its portfolio spans women’s intimate healthcare (Balance Activ), ENT care (Earol), energy and glucose management and hypoglycaemia (Lift and Glucogel), and hormonal lifecycle support (Health & Her), with products recommended by pharmacists and healthcare practitioners and sold through health and beauty retailers, pharmacies, grocery chains and e-commerce channels worldwide, either directly in key markets such as the UK, Ireland and the US or via international distribution partners elsewhere.

Average Trading Volume: 187,830

Technical Sentiment Signal: Buy

Current Market Cap: £85.27M

For detailed information about VLG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1